Pathogenic XPO1 variants cause a dominant neurodevelopmental disorder

Genet Med. 2025 Nov;27(11):101555. doi: 10.1016/j.gim.2025.101555. Epub 2025 Aug 13.

Abstract

Purpose: XPO1 functions in key cellular processes, including nucleo-cytoplasmic export and mitosis. The gene is deleted in a subset of patients with the 2p15p16.1 microdeletion syndrome; however, no monogenic XPO1-related disorder has been described to date.

Methods: We collected clinical data of individuals with de novo XPO1 variants through online matchmaking. We used Drosophila to study XPO1 function in development and habituation learning.

Results: A total of 22 individuals met the criteria to be included in the main study cohort. Of these, half have putative loss-of-function variants, and half have coding variants (10 missense and 1 in-frame deletion variant). We found an overlapping phenotype, consistent with a monogenic neurodevelopmental disorder. We demonstrate XPO1 functions in development by ubiquitous and neuron-specific knockdown in Drosophila. GABAergic neuron specific knockdown flies demonstrated impaired habituation.

Conclusion: Our results establish XPO1 as a novel dominant monogenic neurodevelopmental disorder gene and demonstrate a central role for XPO1 in development.

Keywords: Dominant inheritance; Habituation; Mendelian disorders; Monogenic NDD; XPO1.

MeSH terms

  • Adolescent
  • Adult
  • Animals
  • Child
  • Child, Preschool
  • Drosophila / genetics
  • Drosophila melanogaster
  • Exportin 1 Protein
  • Female
  • Humans
  • Karyopherins* / genetics
  • Karyopherins* / metabolism
  • Male
  • Neurodevelopmental Disorders* / genetics
  • Neurodevelopmental Disorders* / pathology
  • Phenotype
  • Receptors, Cytoplasmic and Nuclear* / genetics
  • Receptors, Cytoplasmic and Nuclear* / metabolism

Substances

  • Exportin 1 Protein
  • Receptors, Cytoplasmic and Nuclear
  • Karyopherins